Skip to content

Japanese Extracranial-Intracranial Arterial Bypass Trial-2 Study

Japanese Extracranial-Intracranial Arterial Bypass Trial-2 Study - JET-2 Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-C000000171
Enrollment
200
Registered
2005-09-13
Start date
2004-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic occlusion or stenosis of internal carotid artery or middle cerebral artery

Interventions

None listed

Sponsors

JET-2 Study Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Recently symptomatic cerebral ischemic attacks due to occlusive lesions in the carotid territory demonstrated by cerebral angiography or magnetic resonance angiography. Transient ischemic attack (TIA) or ischemic minor stroke in the hemispheric carotid territory on the side of the occlusive lesions. Most recent qualifying TIA or stroke occurring within 6 months prior to enrollment. Age less than or equal to 73 years old. Modified Rankin Scale: 0-2. Competent to give informed consent Computed tomography (CT) or MRI demonstrating no diffuse cerebral infarction or no enhancement after infusion of contrast agent. Angiography showing occlusion or severe stenosis of internal carotid artery or middle cerebral artery trunk (M1). Quantitative measurement of cerebral blood flow (CBF) by positron emission tomography (PET), single photon emission computed tomography (SPECT), xenon-CT performed at least 3 weeks after the most recent attack. Cerebrovascular reserve capacity (CVR) is defined as [(CBF after infusion of acetazolamide-rest CBF)/ rest CBF] X 100% Definition of Groups Mild cerebral ischemia is classified into 4 groups based on the rest CBF and CVR. A: 80%<Rest CBF<90% AND CVR<10% B: Rest CBF<80% AND 10%<CVR<20% C:80%<RestCBF<90% AND10%<CVR<20% D: Rest CBF<90% AND 20%<CVR<30%

Exclusion criteria

Exclusion criteria: 1. Severe neurological conditions (Rankin disability scale 3,4,5) 2. Non-atherosclerotic vascular disease of caotid artery territory 3. Malignancy, renal insufficiency, heart failure, hepatic failure, renal failure 4. Acute myocardial infarction within previous 6months 5. Fasting glucose level > 300mg/dl, 6. Diastolic blood pressure >110mmHg 7. Artery to artery embolism 8. Cardioembolism 9. Acute, progressing or unstable neurological deficit

Design outcomes

Primary

MeasureTime frame
1.Completed stroke (Rankin disability scale3,4,5) 2.Vascular death 3.Death and severe disability of other causes 4.Bypass surgery requested by neurologists due to impending stroke on the ipsilateral side

Secondary

MeasureTime frame
1.Ipsilateral stroke (Rankin disability scale3,4,5) 2.Death due to ipsilateral stroke

Countries

Japan

Contacts

Public ContactKoji Iihara

National Cardiovascular Center Neurosurgery

kiihara@hsp.ncvc.go.jp06-6833-5012

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026